Tumor-intrinsic mechanisms involve loss of antigen presentation (HLA class I loss via immunoediting), JAK/IFNGR1 mutations impairing interferon signaling, and upregulation of LAG3/TIM-3/CTLA-4 checkpoints [149,150]. Here, CTLA4 is linked to neoplasm.